圖形 - 獅子山 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
圖形 - 獅子山 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
表 - 獅子山 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
Date
Export Countries
2020
2021
2022
2023
2024
比利時
1.141.975
10.197.685
25.787.193
27.316.500
7.292.084
美國
533.800
5.228.843
7.595.200
4.029.502
327.925
義大利
990.547
6.832.514
497.171
17.754
荷蘭
141.014
2.026.775
3.161.003
39.062
24.363
韩国
2.719.000
78.000
933.000
313.000
620.000
日本
1.601.512
291.563
1.030.740
67.708
373.218
德國
2.472
8.978
1.389.059
698.747
法國
215.297
1.189.053
巴西
118.000
478.784
211.072
206.080
中國大陸
168.225
133.450
27.314
73.024
21.730
Others
226.043
8.695
13.231
15.010
7.525
Total
6,867,338
20,632,372
46,980,327
32,557,056
9,383,347
圖形 - 獅子山 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
圖形 - 獅子山 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
表 - 獅子山 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
Date
Export Countries
08 - 2024
09 - 2024
10 - 2024
11 - 2024
12 - 2024
01 - 2025
比利時
2.745.282
01
283.506
63.908
45.263
德國
698.747
韩国
313.000
316.000
日本
196.054
美國
12.728
13.274
中國大陸
21.730
荷蘭
5.110
949
義大利
2.312
南非
1.492
240
羅馬尼亞
940
Total
3,268,556
704,099
21,730
299,093
64,857
362,203
圖形 - 獅子山 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
圖形 - 獅子山 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
表 - 獅子山 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
Date
Import Countries
2020
2021
2022
2023
2024
台灣
200.000
70.000
193.000
171.000
以色列
215.000
美國
3.736
法國
1.767
261
西班牙
586
297
937
93
比利時
169
120
209
荷蘭
186
Total
200,000
285,755
193,483
177,560
562
圖形 - 獅子山 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
圖形 - 獅子山 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
表 - 獅子山 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
Date
Import Countries
09 - 2024
11 - 2024
比利時
172
西班牙
93
Total
93
172
圖形 - 獅子山 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
圖形 - 獅子山 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
表 - 獅子山 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
Date
Export Countries
2020
2021
2022
2023
2024
Importaciones
比利時
1.141.975
10.197.685
25.787.193
27.316.500
7.292.084
美國
533.800
5.228.843
7.595.200
4.029.502
327.925
義大利
990.547
6.832.514
497.171
17.754
荷蘭
141.014
2.026.775
3.161.003
39.062
24.363
韩国
2.719.000
78.000
933.000
313.000
620.000
日本
1.601.512
291.563
1.030.740
67.708
373.218
德國
2.472
8.978
1.389.059
698.747
法國
215.297
1.189.053
巴西
118.000
478.784
211.072
206.080
中國大陸
168.225
133.450
27.314
73.024
21.730
Others
226.043
8.695
13.231
15.010
7.525
Total
6,867,338
20,632,372
46,980,327
32,557,056
9,383,347
Date
Import Countries
2020
2021
2022
2023
2024
Exportaciones
台灣
200.000
70.000
193.000
171.000
以色列
215.000
美國
3.736
法國
1.767
261
西班牙
586
297
937
93
比利時
169
120
209
荷蘭
186
Total
200,000
285,755
193,483
177,560
562
圖形 - 獅子山 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
圖形 - 獅子山 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
表 - 獅子山 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD